Pictet Asset Management
SLS icon

Pictet Asset Management’s SELLAS Life Sciences SLS Stock Holding History

Pictet Asset Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Buy
+23,984
New +$166K ﹤0.01% 1698

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pictet Asset Management's SLS Position: Q2 2026 in Review

Pictet Asset Management opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 23,984 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #1698 among its holdings.

92 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Pictet Asset Management held 23,984 shares of SELLAS Life Sciences worth $354K as of Q2 2026.
  • SELLAS Life Sciences was a new Pictet Asset Management position in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1698 holding.
  • 92 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.